Therapy News and Research

RSS

UTA developing SMART bandage system that can monitor, cure wounds in real time

The University of Texas at Arlington is developing a sensing and therapeutic tool that will help doctors and other healthcare workers better monitor and heal patients' complex wounds more quickly.

5 Nov 2015

Drugs that target malignant cells increase life expectancy in advanced breast cancer patients

Clinical studies show that new drugs that target malignant cells of HER2-positive breast cancer, such as Pertuzumab and Trastuzumab Emtansine (T-DM1), increase life expectancy in patients with advanced breast cancer.

5 Nov 2015

Researchers successfully repair nerve cell damage in Alzheimer's dementia

In laboratory experiments on the basic mechanisms that cause Alzheimer's dementia, an international research team led by Heidelberg neurobiologist Prof. Dr. Ulrike Müller and a team of French scientists have succeeded in largely "repairing" the nerve cell damage typical in this disease.

5 Nov 2015

CK5 protein marks ovarian cancer likely to be resistant to cisplatin

A University of Colorado Cancer Center study recently published in the International Journal of Gynecological Cancer shows that protein cytokeratin 5 (CK5), known to be a marker of poor prognosis in breast cancer, also marks ovarian cancers likely to be resistant to the common chemotherapy cisplatin.

5 Nov 2015

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

New results from the Treatment Options for Type 2 Diabetes in Youth study (TODAY) examined predictors of the outcomes in youth with onset type 2 diabetes (T2D) based on early characteristics at diagnosis, and suggests the need for specific criteria for adolescents that are different from those in adults.

5 Nov 2015

Quad introduces MagCloudz Streptavidin Cell Separation Kit to redefine translational medical research

The most promising areas of translational medical research, including CAR-T cancer therapies and stem cell-based regenerative medicine, require the isolation and purification of large numbers of viable, functional cells.

5 Nov 2015

Nucala (mepolizumab) approved for treatment of asthma patients

The U.S. Food and Drug Administration today approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older. Nucala is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current asthma medicines.

5 Nov 2015

EndoGastric Solutions announces assignment of relative value units for new CPT code covering TIF procedure

EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the Federal Register has posted coding and payment information specific to the new Current Procedural Terminology (CPT)® code covering the Transoral Incisionless Fundoplication (TIF®) procedure.

4 Nov 2015

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.

4 Nov 2015

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Johnson & Johnson today announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.

4 Nov 2015

New network formed to provide area-wide care for lung cancer patients in Northern Germany

The Pius Hospital Oldenburg, the Institute of Haematopathology Hamburg and NEO New Oncology AG announced today the formation of NOWEL, the North-East-West Lung Network.

4 Nov 2015

Estradiol fluctuation may enhance emotional sensitivity to psychosocial stress during menopausal transition

If you're feeling a little blue during the transition to menopause, there's good reason, according to a new study being reported online today in Menopause, the journal of The North American Menopause Society (NAMS). The study from the Department of Psychiatry at the University of North Carolina at Chapel Hill suggests that the estradiol (a form of estrogen) fluctuation that is common during the menopausal transition may enhance emotional sensitivity to psychosocial stress.

4 Nov 2015

New Swedish study questions treatment of female infertility with stem cell therapy

It has been claimed that a treatment for female infertility will be available by stem cell therapy. But a new study by Swedish researchers from the University of Gothenburg and Karolinska Institutet published in Nature Medicine questions whether new egg cells can be produced using stem cells.

4 Nov 2015

Study explores benefits of breast cancer adjuvant therapies

After breast cancer surgery, women are prescribed adjuvant (or follow-up) therapies such as chemotherapy and endocrine drugs to reduce the risk of the cancer returning. It's been assumed that the treatment effects of these therapies remain constant over time, but a new study from the Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio suggests the opposite is true.

4 Nov 2015

New clinical trial uses aggressive treatment method for patients with pancreas cancer

Pancreas cancer remains one of the deadliest cancers worldwide. In the United States, it accounts for only three percent of all diagnosed cancers but it causes almost seven percent of all cancer deaths. A pancreas cancer diagnosis often comes after age 50 and after the cancer has spread, making it difficult to remove surgically.

4 Nov 2015

Chemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric brain tumor survivors

More children are surviving malignant brain tumors than in the past, thanks to the use of intense treatments using platinum-based chemotherapy (cisplatin and high-dose carboplatin). Unfortunately, the therapy has a known side effect of permanent hearing loss, resulting from damage to the inner ear.

4 Nov 2015

Scientists propose that Alzheimer's disease should be treated separately

Deciphering the mechanism that underlies the development of Alzheimer's disease in certain families but not in others, researchers at the Hebrew University of Jerusalem's Faculty of Medicine have proposed that the malady is actually a collection of diseases that probably should be treated with a variety of different approaches.

4 Nov 2015

Therapy News and Research

UTA developing SMART bandage system that can monitor, cure wounds in real time

Drugs that target malignant cells increase life expectancy in advanced breast cancer patients

Researchers successfully repair nerve cell damage in Alzheimer's dementia

CK5 protein marks ovarian cancer likely to be resistant to cisplatin

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

Quad introduces MagCloudz Streptavidin Cell Separation Kit to redefine translational medical research

Nucala (mepolizumab) approved for treatment of asthma patients

EndoGastric Solutions announces assignment of relative value units for new CPT code covering TIF procedure

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

New network formed to provide area-wide care for lung cancer patients in Northern Germany

Estradiol fluctuation may enhance emotional sensitivity to psychosocial stress during menopausal transition

New Swedish study questions treatment of female infertility with stem cell therapy

Study explores benefits of breast cancer adjuvant therapies

New clinical trial uses aggressive treatment method for patients with pancreas cancer

Chemotherapy treatment can contribute to long-term neurocognitive deficits in pediatric brain tumor survivors

Scientists propose that Alzheimer's disease should be treated separately

‘Zero pressure’ mattress solutions to be showcased at MEDICA 2015

Innovative immunotherapy clinical trial underway at The University of Kansas Cancer Center

Approval to start trial of Videregen's replacement trachea technology

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News